[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:mesothelial-neoplasm":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":249,"states":260},"Mesothelial Neoplasm",39,34,[8,16,22,29,35,41,47,53,59,65,71,77,83,89,95,101,107,113,119,125,131,137,143,149,156,162,168,174,180,186,192,198,204,210,216,223,230,236,243],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06251310","SW-682 in Advanced Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:18:38.077159Z","2026-05-05T02:43:28.970517Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06885697","Anti-Mesothelin TNaive\u002FSCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma",[12],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:27.985101Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT05932199","Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma",[26],"Phase 1\u002FPhase 2","2026-08-26T02:18:31.944757Z","2026-04-29T02:57:57.109886Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05873686","A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers",[12],"2026-08-26T02:17:00.709807Z","2026-07-19T19:36:05.121267Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07563738","A 2-part Phase 1\u002F2 Open-label Trial on ODM-212",[26],"2026-08-26T02:15:26.669629Z","2026-05-13T02:55:06.727821Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT04665206","Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors",[26],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:29.217787Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT05627960","First in Human Phase 1 Study of AG01 Anti-Progranulin\u002FGP88 Antibody in Advanced Solid Tumor Malignancies",[12],"2026-08-26T02:17:38.215063Z","2026-05-05T02:43:27.807114Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT06452160","A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors",[12],"2026-08-26T02:17:29.353236Z","2026-05-05T02:43:27.312630Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT05579366","Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01\u002F PRO1184-001)",[26],"2026-08-26T02:17:02.694423Z","2026-07-05T05:32:16.807199Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT04104776","A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas",[26],"2026-08-26T02:17:15.156099Z","2026-07-05T05:32:16.792523Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT07277413","A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",[12],"2026-08-26T02:16:01.910993Z","2026-07-05T05:32:16.679197Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT07354100","Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy",[26],"2026-08-26T02:18:52.966503Z","2026-06-17T02:29:30.060269Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT06725758","A Phase 1\u002F2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours",[26],"2026-08-26T02:18:25.327036Z","2026-05-13T02:55:06.568386Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT07197671","Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer",[12],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.735881Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT06444815","A Study of VET3-TGI in Patients With Solid Tumors",[12],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:29.507169Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT06710756","Lead-212 PSV359 Therapy for Patients With Solid Tumors",[26],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.400599Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT05732831","Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors",[26],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:27.947953Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT04115254","Stereotactic Magnetic Resonance Guided Radiation Therapy",[],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:27.421536Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT06051695","A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression",[26],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:26.963212Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT05245500","Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion",[12],"2026-08-26T02:18:27.904411Z","2026-05-05T02:43:26.709142Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT05568680","SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma",[12],"2026-08-26T02:15:31.806698Z","2026-05-05T02:35:31.692599Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT03556228","VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma",[26],"2026-08-26T02:16:45.157238Z","2026-05-05T02:35:31.649315Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT06538376","Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU",[],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:28.345811Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":154,"content_modified":155},"NCT06503146","18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection",[153],"Phase 2","2026-08-26T02:18:24.494016Z","2026-05-05T02:35:31.918317Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT03830229","Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1",[],"2026-08-26T02:17:59.904383Z","2026-07-05T05:32:16.771041Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT04431024","Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome",[],"2026-08-26T02:16:16.995720Z","2026-06-18T12:24:02.760803Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT00280202","Detection of Genetic Markers of Lung Cancer",[],"2026-08-26T02:15:25.633039Z","2026-05-13T02:55:06.033277Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT07705334","A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors",[12],"2026-08-26T02:17:32.059863Z","2026-07-19T19:36:05.087283Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":184,"content_modified":185},"NCT01950572","Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma",[],"2026-08-26T02:18:59.761994Z","2026-07-05T05:32:16.769586Z",{"nct_id":187,"title":188,"phases":189,"status":13,"updated_at":190,"content_modified":191},"NCT05585684","Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection",[],"2026-08-26T02:18:45.196599Z","2026-05-13T02:55:06.364182Z",{"nct_id":193,"title":194,"phases":195,"status":13,"updated_at":196,"content_modified":197},"NCT04981119","Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.276659Z",{"nct_id":199,"title":200,"phases":201,"status":13,"updated_at":202,"content_modified":203},"NCT04792463","Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome",[],"2026-08-26T02:15:56.561131Z","2026-05-13T02:55:06.269987Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT02012699","Integrated Cancer Repository for Cancer Research",[],"2026-08-26T02:16:35.654046Z","2026-05-13T02:55:06.082833Z",{"nct_id":211,"title":212,"phases":213,"status":13,"updated_at":214,"content_modified":215},"NCT05547321","Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.",[12],"2026-08-26T02:15:54.846520Z","2026-05-05T02:43:28.476219Z",{"nct_id":217,"title":218,"phases":219,"status":220,"updated_at":221,"content_modified":222},"NCT06791057","Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer",[],"NOT_YET_RECRUITING","2026-08-26T02:16:13.426928Z","2026-05-05T02:43:26.695019Z",{"nct_id":224,"title":225,"phases":226,"status":227,"updated_at":228,"content_modified":229},"NCT01385722","Molecular Analysis of Thoracic Malignancies",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:16.126291Z","2026-06-16T05:54:07.945274Z",{"nct_id":231,"title":232,"phases":233,"status":227,"updated_at":234,"content_modified":235},"NCT06885424","A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products",[],"2026-08-26T02:15:44.309045Z","2026-06-16T05:54:07.838264Z",{"nct_id":237,"title":238,"phases":239,"status":240,"updated_at":241,"content_modified":242},"NCT03935893","Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers",[153],"ACTIVE_NOT_RECRUITING","2026-08-03T03:19:35.241322Z","2026-05-05T02:43:26.987294Z",{"nct_id":244,"title":245,"phases":246,"status":240,"updated_at":247,"content_modified":248},"NCT06396598","Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer",[],"2026-08-03T03:02:05.931134Z","2026-04-29T02:57:57.104461Z",[250,254,257],{"biomarker":251,"count":252,"slug":253},"MRC1 wt Allele",3,"mrc1-wt-allele",{"biomarker":255,"count":252,"slug":256},"MSLN Gene","msln-gene",{"biomarker":258,"count":252,"slug":259},"MTAP Gene","mtap-gene",[261,265,269,273,276,280,283,286,290,294,297,301,305,309,312,316,319,322,325,329,332,335,338,341],{"state":262,"count":263,"slug":264},"Texas",18,"texas",{"state":266,"count":267,"slug":268},"Florida",14,"florida",{"state":270,"count":271,"slug":272},"California",12,"california",{"state":274,"count":271,"slug":275},"New York","new-york",{"state":277,"count":278,"slug":279},"Maryland",11,"maryland",{"state":281,"count":278,"slug":282},"Massachusetts","massachusetts",{"state":284,"count":278,"slug":285},"Ohio","ohio",{"state":287,"count":288,"slug":289},"Pennsylvania",10,"pennsylvania",{"state":291,"count":292,"slug":293},"Minnesota",9,"minnesota",{"state":295,"count":292,"slug":296},"Virginia","virginia",{"state":298,"count":299,"slug":300},"Arizona",8,"arizona",{"state":302,"count":303,"slug":304},"Illinois",7,"illinois",{"state":306,"count":307,"slug":308},"Tennessee",6,"tennessee",{"state":310,"count":307,"slug":311},"Washington","washington",{"state":313,"count":314,"slug":315},"Colorado",5,"colorado",{"state":317,"count":314,"slug":318},"Missouri","missouri",{"state":320,"count":314,"slug":321},"New Jersey","new-jersey",{"state":323,"count":314,"slug":324},"Wisconsin","wisconsin",{"state":326,"count":327,"slug":328},"Kansas",4,"kansas",{"state":330,"count":327,"slug":331},"Michigan","michigan",{"state":333,"count":327,"slug":334},"Utah","utah",{"state":336,"count":252,"slug":337},"Nebraska","nebraska",{"state":339,"count":252,"slug":340},"North Carolina","north-carolina",{"state":342,"count":252,"slug":343},"Oregon","oregon"]